Sino Biopharmaceutical Limited (SBHMY)
USD 8.34
(0.0%)
USD 8.34
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.37 Billion CNY | -67.76% |
| 2022 | 4.25 Billion CNY | -23.03% |
| 2021 | 5.53 Billion CNY | -56.19% |
| 2020 | 12.62 Billion CNY | 59.33% |
| 2019 | 7.92 Billion CNY | 1463.12% |
| 2018 | 507.06 Million CNY | -77.05% |
| 2017 | 2.2 Billion CNY | 31.69% |
| 2016 | 1.67 Billion CNY | 554.74% |
| 2015 | 256.29 Million CNY | -75.13% |
| 2014 | 1.03 Billion CNY | 1470.8% |
| 2013 | -75.16 Million CNY | -569.07% |
| 2012 | 16.02 Million CNY | -42.69% |
| 2011 | 27.96 Million CNY | -74.18% |
| 2010 | 108.28 Million CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | -100.0% |
| 2007 | 20.02 Million CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| 2005 | - CNY | -100.0% |
| 2004 | 45.7 Million CNY | -45.04% |
| 2003 | 83.16 Million CNY | 0.0% |
| 2002 | - CNY | 0.0% |
| 2001 | - CNY | 0.0% |
| 2000 | - CNY | 0.0% |
| 1999 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.01 Billion CNY | 0.0% |
| 2024 Q1 | 1.01 Billion CNY | -5.99% |
| 2023 Q3 | 1.37 Billion CNY | 33.11% |
| 2023 Q4 | 1.37 Billion CNY | 0.0% |
| 2023 Q2 | 1.03 Billion CNY | 0.0% |
| 2023 FY | 1.37 Billion CNY | -67.76% |
| 2023 Q1 | 1.03 Billion CNY | -75.78% |
| 2022 Q3 | 4.25 Billion CNY | -46.09% |
| 2022 FY | 4.25 Billion CNY | -23.03% |
| 2022 Q4 | 4.25 Billion CNY | 0.0% |
| 2022 Q1 | 7.89 Billion CNY | 42.77% |
| 2022 Q2 | 7.89 Billion CNY | 0.0% |
| 2021 Q4 | 5.53 Billion CNY | 0.0% |
| 2021 FY | 5.53 Billion CNY | -56.19% |
| 2021 Q1 | 12.58 Billion CNY | -0.38% |
| 2021 Q3 | 5.53 Billion CNY | -53.14% |
| 2021 Q2 | 11.8 Billion CNY | -6.15% |
| 2020 Q3 | 13.93 Billion CNY | -3.35% |
| 2020 FY | 12.62 Billion CNY | 59.33% |
| 2020 Q1 | 13.88 Billion CNY | 75.16% |
| 2020 Q2 | 14.42 Billion CNY | 3.87% |
| 2020 Q4 | 12.62 Billion CNY | -9.39% |
| 2019 Q1 | 541.63 Million CNY | 6.82% |
| 2019 Q2 | 2.46 Billion CNY | 354.93% |
| 2019 Q4 | 7.92 Billion CNY | 210.45% |
| 2019 FY | 7.92 Billion CNY | 1463.12% |
| 2019 Q3 | 2.55 Billion CNY | 3.61% |
| 2018 Q4 | 507.06 Million CNY | -6.8% |
| 2018 Q3 | 544.05 Million CNY | -75.42% |
| 2018 Q2 | 2.21 Billion CNY | 4.39% |
| 2018 Q1 | 2.12 Billion CNY | -4.04% |
| 2018 FY | 507.06 Million CNY | -77.05% |
| 2017 Q2 | 1.63 Billion CNY | -1.59% |
| 2017 Q4 | 2.2 Billion CNY | -2.36% |
| 2017 FY | 2.2 Billion CNY | 31.69% |
| 2017 Q1 | 1.65 Billion CNY | -1.14% |
| 2017 Q3 | 2.26 Billion CNY | 38.64% |
| 2016 Q1 | 272.29 Million CNY | 6.24% |
| 2016 FY | 1.67 Billion CNY | 554.74% |
| 2016 Q4 | 1.67 Billion CNY | 73.36% |
| 2016 Q3 | 967.94 Million CNY | 251.16% |
| 2016 Q2 | 275.64 Million CNY | 1.23% |
| 2015 FY | 256.29 Million CNY | -75.13% |
| 2015 Q1 | 1.3 Billion CNY | 26.22% |
| 2015 Q2 | 1.3 Billion CNY | 0.42% |
| 2015 Q3 | 1.33 Billion CNY | 2.27% |
| 2015 Q4 | 256.29 Million CNY | -80.81% |
| 2014 Q3 | 1.02 Billion CNY | -0.88% |
| 2014 FY | 1.03 Billion CNY | 1470.8% |
| 2014 Q4 | 1.03 Billion CNY | 0.17% |
| 2014 Q1 | 189.38 Million CNY | 18969266544419816.0% |
| 2014 Q2 | 1.03 Billion CNY | 447.99% |
| 2013 FY | -75.16 Million CNY | -569.07% |
| 2013 Q3 | 15.92 Million CNY | -0.87% |
| 2013 Q2 | 16.06 Million CNY | -33.12% |
| 2013 Q1 | 24.02 Million CNY | 49.92% |
| 2013 Q4 | - CNY | -100.0% |
| 2012 FY | 16.02 Million CNY | -42.69% |
| 2012 Q4 | 16.02 Million CNY | -38.36% |
| 2012 Q3 | 25.99 Million CNY | -0.13% |
| 2012 Q2 | 26.03 Million CNY | 0.0% |
| 2011 Q3 | 88.19 Million CNY | -18.4% |
| 2011 Q2 | 108.08 Million CNY | -0.14% |
| 2011 Q1 | 108.23 Million CNY | 0.0% |
| 2011 FY | 27.96 Million CNY | -74.18% |
| 2011 Q4 | 27.96 Million CNY | -68.29% |
| 2010 Q2 | 61.84 Million CNY | 0.0% |
| 2010 FY | 108.28 Million CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2009 Q4 | - CNY | 0.0% |
| 2008 FY | - CNY | -100.0% |
| 2007 FY | 20.02 Million CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |
| 2005 FY | - CNY | -100.0% |
| 2004 FY | 45.7 Million CNY | -45.04% |
| 2003 FY | 83.16 Million CNY | 0.0% |
| 2002 FY | - CNY | 0.0% |
| 2001 FY | - CNY | 0.0% |
| 2000 FY | - CNY | 0.0% |
| 1999 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | - USD | -Infinity% |
| Nanobac Pharmaceuticals, Incorporated | - USD | -Infinity% |
| SQZ Biotechnologies Company | 20.9 Million USD | -6465.67% |
| Evofem Biosciences, Inc. | 8000.00 USD | -17160100.0% |
| Santhera Pharmaceuticals Holding AG | 1.75 Million USD | -78101.79% |
| Mesoblast Limited | 100.29 Million USD | -1268.779% |
| Propanc Biopharma, Inc. | 58.64 Thousand USD | -2340911.562% |
| Genus plc | 228.2 Million USD | -501.585% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | - USD | -Infinity% |
| Marizyme, Inc. | 667.12 Thousand USD | -205679.692% |
| ContraFect Corporation | 2.21 Million USD | -62018.371% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.4 Million USD | -97753.213% |
| Intellipharmaceutics International Inc. | - USD | -Infinity% |
| AXIM Biotechnologies, Inc. | 5.42 Million USD | -25198.462% |
| MultiCell Technologies, Inc. | 36.43 USD | -3768366630.716% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 55.61 Million USD | -2368.561% |
| EV Biologics, Inc. | - USD | -Infinity% |
| Q BioMed Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 2.22 Million USD | -61571.878% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -111659.979% |
| Biomind Labs Inc. | - USD | -Infinity% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | -726.475% |
| Oncotelic Therapeutics, Inc. | 1.89 Million USD | -72211.78% |
| Skye Bioscience, Inc. | 171.23 Thousand USD | -801638.013% |
| Therapeutic Solutions International, Inc. | 5512.00 USD | -24905850.653% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | - USD | -Infinity% |
| IMV Inc. | 27.39 Million USD | -4910.539% |
| Acro Biomedical Co., Ltd. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | 322 Thousand USD | -426240.373% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 11.23 Billion USD | 87.785% |
| Halberd Corporation | 150 Thousand USD | -915110.667% |
| Enzolytics Inc. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 300 Thousand USD | -457505.333% |
| Nuo Therapeutics, Inc. | 164.2 Thousand USD | -835937.879% |
| argenx SE | 15.35 Million USD | -8841.097% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 20.31 Million USD | -6658.645% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 4456.00 USD | -30808158.528% |
| Genscript Biotech Corporation | 287.12 Million USD | -378.118% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 126.3 Thousand USD | -1086831.323% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -598622.148% |
| American Oriental Bioengineering, Inc. | 554.59 Thousand USD | -247437.099% |
| Provectus Biopharmaceuticals, Inc. | 25.29 Thousand USD | -5426264.678% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 8.26 Million USD | -16512.004% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 265.63 Thousand USD | -516705.391% |
| ONE Bio Corp. | 592.19 Thousand USD | -231717.061% |
| Reve Technologies, Inc. | 1064.00 USD | -129023960.15% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -917471.885% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -917471.885% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | - USD | -Infinity% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | 229.69 Thousand USD | -597579.491% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | 141 Thousand USD | -973528.369% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 80 Thousand USD | -1715920.0% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -17455.282% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 369.04 Thousand USD | -371887.46% |
| International Stem Cell Corporation | 445 Thousand USD | -308397.978% |
| Bioxytran, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.15 Million USD | -16744.368% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | 457 Thousand USD | -300297.374% |
| Neutra Corp. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 1.16 Million USD | -118144.272% |
| PureTech Health plc | 18.25 Million USD | -7422.279% |
| Coeptis Therapeutics, Inc. | 150 Thousand USD | -915110.667% |
| IXICO plc | 275 Thousand USD | -499105.818% |
| IntelGenx Technologies Corp. | 11.83 Million USD | -11495.709% |
| Gelesis Holdings, Inc. | 26.3 Million USD | -5118.047% |
| CSL Limited | 11.23 Billion USD | 87.785% |
| Cellectis S.A. | 36.21 Million USD | -3691.142% |